ALLMedicine™ Bacterial Vaginosis Center

May 5th, 2021 - A large proportion of women in Odisha, India, use reusable absorbents to manage their menstruation. Yet, the risk factors for lower reproductive tract infections (RTIs) related to menstrual hygiene management (MHM) have not been studied among reus...

Apr 26th, 2021 - The main focus of the current work was to design, evaluate and clinically compare the efficiency of novel metronidazole (MTD) loaded solid lipid nanoparticles (SLNs) vaginal emulgel with the marketed vaginal gel (Metron®) against Bacterial vaginos...

Apr 7th, 2021 - Bacterial vaginosis (BV) is a condition of the vaginal microbiome in which there are few lactobacilli and abundant anaerobic bacteria. Members of the genus Gardnerella are often one of the most abundant bacteria in BV. BV is associated with a wide...

Mar 22nd, 2021 - Bacterial vaginosis is a frequent source of vaginal infection among reproductive-aged women. Astodrimer gel is a novel drug which demonstrated favourable outcomes for treatment of patients with bacterial vaginosis. We attempted to conduct a system...

Mar 22nd, 2021 - Given the frequency of recurrent bacterial vaginosis (RBV), enhancing treatment and preventing recurrence have become the central target of pharmacotherapy today. Antimicrobial failure is occurring at a time when knowledge of pathogenesis of bacte...

Apr 7th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...

Oct 7th, 2019 - The USPSTF recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.

Jul 21st, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...

Jun 4th, 2015

May 23rd, 2015 - To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and com...

May 5th, 2021 - A large proportion of women in Odisha, India, use reusable absorbents to manage their menstruation. Yet, the risk factors for lower reproductive tract infections (RTIs) related to menstrual hygiene management (MHM) have not been studied among reus...

Apr 26th, 2021 - The main focus of the current work was to design, evaluate and clinically compare the efficiency of novel metronidazole (MTD) loaded solid lipid nanoparticles (SLNs) vaginal emulgel with the marketed vaginal gel (Metron®) against Bacterial vaginos...

Apr 7th, 2021 - Bacterial vaginosis (BV) is a condition of the vaginal microbiome in which there are few lactobacilli and abundant anaerobic bacteria. Members of the genus Gardnerella are often one of the most abundant bacteria in BV. BV is associated with a wide...

Apr 7th, 2021 - NUVESSA is indicated for the treatment of bacterial vaginosis in females 12 years of age and older. NUVESSA™ is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in females 12 years of age and older. (1)

Mar 22nd, 2021 - Bacterial vaginosis is a frequent source of vaginal infection among reproductive-aged women. Astodrimer gel is a novel drug which demonstrated favourable outcomes for treatment of patients with bacterial vaginosis. We attempted to conduct a system...

Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Mar 29th, 2020 - Safety and next steps The safety analysis showed that side effects were generally mild and well tolerated. There were 161 adverse events among 29 women for whom safety data were available.

Oct 8th, 2019 - Insufficient evidence exists to recommend routine screening for pregnant women at higher risk of preterm birth for bacterial vaginosis, the U.S. Preventive Services Task Force (USPSTF) said. There was not enough evidence to determine the benefits ...